GlassScriptPhysician profile
Kimberly A Murphy
NPI 1720374853
$1,245.57
in general payments reported to CMS, 2019-2025
7 companies · $631 in 2025
The $631 reported for 2025 was more than what 92% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2021: $32.31 · 2022: $48.44 · 2023: $20.27 · 2024: $367 · 2025: $631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,018.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,018.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $515.33 | 2024-2025 | Watchman Flx, Watchman Access System |
| Edwards Lifesciences Corporation | $294.42 | 2019-2025 | Konect Resilia, Inspiris Resilia Aortic Valve, Mitris Resilia Mitral Valve |
| Astrazeneca Pharmaceuticals LP | $124.98 | 2024 | Andexxa |
| Abiomed | $120.23 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $74.46 | 2019 | |
| Ethicon US, LLC | $67.71 | 2023-2024 | Stratafix, Vistaseal, Echelon Flex |
| La Jolla Pharmaceutical Company | $48.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.